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Acute Onset Human Atrial
Fibrillation Is Associated With Local Cardiac
Platelet Activation and Endothelial Dysfunction
Joseph G. Akar, MD, PHD, Walter Jeske, PHD, David J. Wilber, MD
Maywood, Illinois
Objectives The purpose of this study was to determine whether acute onset atrial fibrillation (AF), independent of other risk
factors, predisposes to an early prothrombotic state.
Background Several risk factors predispose to the hypercoagulable state in human AF, but whether acute onset AF alone is
prothrombotic remains unclear.
Methods Patients with paroxysmal AF (n  22) underwent radiofrequency catheter ablation. All patients presented in
sinus rhythm. Baseline blood samples were obtained simultaneously from the femoral vein (systemic sample)
and the coronary sinus (local cardiac sample). The AF was induced by burst atrial pacing in 14 patients (AF
group). A control group (n  8) underwent atrial pacing at 120 beats/min. Blood samples were recollected after
15 min. Platelet P-selectin expression (CD62) was measured using flow cytometry. Markers of thrombin genera-
tion (thrombin antithrombin complex, prothrombin fragment 1.2), inflammation (C-reactive protein, interleukin-
6), and nitric oxide were measured using enzyme-linked immunosorbent assays.
Results Neither local nor systemic platelet activation changed in the control group. In the AF group, local cardiac platelet
activation (percent P-selectin [] platelets) increased significantly (2.2  0.6% to 2.8  1.0%, p  0.007); how-
ever, systemic platelet activation did not change. The AF group had increased local thrombin generation (throm-
bin antithrombin complex: 8.5 7.6 ng/ml to 33.2  17.4 ng/ml, p  0.003; prothrombin fragment 1.2: 95.6
45.6 mol/l to 243.8  120.1 mol/l, p  0.003), decreased nitric oxide production (25.2  10.8 mol/l to
22.3  10.0 mol/l, p  0.02), and no change in inflammatory markers.
Conclusions Human AF causes local cardiac platelet activation within minutes of onset. The results demonstrate how AF
alone, independent of other risk factors, may contribute to the hypercoagulable state. (J Am Coll Cardiol 2008;
51:1790–3) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.11.083s
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ihether atrial fibrillation (AF) itself causes platelet activa-
ion remains unresolved. Although several risk factors (e.g.,
ge, hypertension, diabetes mellitus, heart failure) predis-
ose to stroke in patients with AF, it has been contro-
ersial whether the arrhythmia itself independently leads
o platelet activation and hypercoagulability (1–6). Stud-
es have yielded conflicting results because heterogeneity
n AF burden and patient profile make it difficult to
issociate the effect of AF on prothrombotic markers from
he effect of other risk factors. Furthermore, it is unclear to
hat degree paroxysmal AF leads to hypercoagulability.
he prothrombotic effects of acute AF likely develop on a
ardiac level before manifesting in the peripheral circulation,
rom the Cardiovascular Institute, Loyola University Medical Center, Maywood,
llinois.i
Manuscript received September 11, 2007; revised manuscript received November
5, 2007, accepted November 19, 2007.o examination of serological markers in peripheral blood
ay not reflect the local cardiac events.
We hypothesized that acute onset human AF leads to
latelet activation on a local cardiac level, independent of
ther risk factors.
ethods
he study was approved by the Institutional Review Board
f Loyola University Medical Center. Written informed
onsent was obtained from all subjects.
tudy protocol. All patients (both groups) had a history of
aroxysmal AF but were in sinus rhythm at the beginning of
he study. The patients presented for radiofrequency AF
blation. Exclusions included left ventricular dysfunction,
heumatic valve disease, mitral valve prolapse, or any valvu-
ar regurgitation more than mild/physiologic. Sheaths were
nserted in the femoral veins and coronary sinus (via right
nternal jugular vein). A quadripolar catheter was positioned
n the high right atrium for pacing.
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May 6, 2008:1790–3 Acute AF and Platelet ActivationDuring baseline sinus rhythm, 10 ml of blood was
imultaneously obtained from the peripheral femoral venous
heath (systemic sample) and the coronary sinus sheath
local cardiac sample). Atrial fibrillation was induced by
urst atrial pacing (cycle length 180 ms) in 14 consecutive
atients (AF group). Following 15 min of AF, simultaneous
ocal and systemic samples were drawn again. No heparin or
ther medication was administered during this time.
The fast ventricular response observed during AF in these
atients (mean 121 beats/min) could theoretically affect the
emostatic system independent of the arrhythmia itself. To
ssess the effect of the ventricular rate, a control group (n 
) underwent atrial pacing at 120 beats/min for 15 min
nstead of burst atrial pacing. These patients also had a
istory of paroxysmal AF. This produced a ventricular
ate equivalent to the AF group; however, the control
atients were not in AF. Local and systemic blood samples
ere drawn before and after pacing. All samples were imme-
iately transferred for analysis in citrated tubes. The inves-
igators were blinded to platelet function results.
ssessment of platelet activation. Platelet P-selectin ex-
ression (CD62) was studied using 2-color whole blood
ow cytometry. Citrated whole blood samples were fixed in
% paraformaldehyde for 30 min and then pelleted, resus-
ended in Tyrode’s buffer, and labeled with CD61-FITC
nd CD62-PE (BD Biosciences, San Jose, California). The
egree of platelet activation was determined as the fraction
f CD61() events that was also CD62().
erological markers of thrombosis, inflammation and
ndothelial function. Serological markers were measured
sing commercially available enzyme-linked immunosor-
ent assays. Samples were run in duplicate and read at
50 nm.
hrombosis. Thrombin antithrombin complex (TAT) and
rothrombin fragment 1.2 (F1.2) were measured (Dade-
ehring, Deerfield, Illinois). Both TAT and F1.2 are
Baseline Characteristics of the Patients
Table 1 Baseline Characteristics of the Pat
Atrial Fibri
Age (yrs) 5
Male gender (%)
Diabetes (%)
Hypertension (%)
Stroke/transient ischemic attack (%)
Ejection fraction (%) 5
Left atrial size (mm) 4
Blood pressure (mm Hg)
Baseline 113
After 15 min 114
Medications (%)
Warfarin
Clopidogrel
Aspirin
Beta-blocker
Calcium-channel blockerDigoxin 7ndependent in vivo markers:
AT of thrombin generation
nd F1.2 of antithrombin con-
umption. The TAT complexes
orm covalently fol lowing
hrombin generation, and F1.2 is
ormed by conversion of pro-
hrombin to thrombin.
nflammation. Inflammation is
ssociated with thrombin genera-
ion, platelet activation, and the pathophysiology of AF.
igh-sensitivity C-reactive protein and interleukin-6 were
easured (American Diagnostica, Greenwich, Connecticut,
nd BD Biosciences, San Jose, California, respectively).
ndothelial function. Quantification of nitric oxide (NO)
roduction was performed using a standard assay (R&D
ystems, Minneapolis, Minnesota), which relies on conver-
ion of nitrate to nitrite and detection as an azo dye product
f the Greiss reaction (7).
tatistics. Data are shown as mean  standard deviation.
omparisons between groups were performed by 2-sample
test, and within each group by paired sample t test.
tatistical significance was defined as p  0.05.
esults
atient characteristics. Patient characteristics are shown
n Table 1. The following medications were withheld ahead
f the procedure: clopidogrel and aspirin—7 days, warfa-
in—5 days, enoxaparin—24 h, antiarrhythmic medica-
ions—3 days. More patients in the control group were
emale and had a history of clopidogrel use; however,
lopidogrel had been discontinued 30 days and thus did
ot affect platelet function. Baseline blood pressure was
imilar in both groups and did not change after 15 min of
ither AF or pacing.
(n  14) Control (n  8) p Value
54 14 0.84
50 0.02
25 0.26
25 0.62
13 0.19
56 6 0.86
48 7 0.34
 16 122 18/72 9 0.34
 18 120 6/80 12 0.40
38 0.94
25 0.05
63 0.24
50 0.34
0 0.46
Abbreviations
and Acronyms
AF  atrial fibrillation
F1.2  prothrombin
fragment 1.2
NO  nitric oxide
TAT  thrombin
antithrombin complexients
llation
4 12
93
7
36
0
6 6
5 6
20/68
17/77
36
0
36
29
738 0.08
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Acute AF and Platelet Activation May 6, 2008:1790–3ocal and peripheral platelet activation in acute AF. Both
eripheral and local cardiac platelet activation were similar
t baseline in the AF and control groups. As shown in
igure 1, local cardiac platelet activation increased signifi-
antly after 15 min of AF; however, it did not significantly
hange with pacing. In contrast, Figure 2 demonstrates that
eripheral platelet activation remained stable and did not
hange following either AF or pacing.
ocal thrombin generation. We hypothesized that the
latelet activation was due to increased thrombin genera-
ion. Local TAT and F1.2 levels were measured at baseline
n sinus rhythm, after 15 min of AF (no heparin), and then
t the conclusion of the AF ablation after the administration
f intravenous heparin (to provide an internal control by
nhibiting thrombin).
As shown in Figures 3A and 3B, local TAT and F1.2
evels increased significantly after 15 min of AF, indicating
ngoing thrombin generation due to the arrhythmia. As
xpected, intravenous heparin reduced thrombin generation
o baseline levels.
nflammation and endothelial dysfunction. We hypoth-
sized that local cardiac thrombin generation and platelet
ctivation in acute AF were secondary to an inflammatory
esponse. However, cardiac C-reactive protein (1.10  0.77
g/ml vs. 1.14  0.78 g/ml, p  0.15) and interleukin-g
3.7  8.3 pg/ml vs. 3.5  8.0 pg/ml, p  0.4) did not
hange following 15 min of AF.
Reduced NO production due to endothelial dysfunction
s a known cause of platelet activation and thrombosis.
ardiac levels of total NO decreased following 15 min of
F (25.2  10.8 vs. 22.3  10.0, p  0.02), indicating that
cute onset AF is associated with endothelial dysfunction.
here was no change in cardiac NO production in the
ontrol group.
Figure 1 Local Cardiac Platelet Activation
Local cardiac platelet activation increased significantly after 15 min of atrial
fibrillation (AF), but did not change after 15 min of atrial pacing. Solid bars 
baseline; open bars  15 min.biscussion
latelet activation and AF. This study demonstrates that
cute onset AF is associated with activation of platelets and
ther prothrombotic markers. These events occur on a local
ardiac level before manifesting in the peripheral circulation
nd are due to AF per se, not to the fast ventricular rate seen
uring the arrhythmia (8).
One study (9) suggested platelet activation was time-
ependent in AF; however, other studies (1–6) yielded
onflicting results. This is partly due to use of peripheral
lood samples from patients with different AF durations.
latelet activation, an early thrombotic event, is expected to
ccur on a cardiac level before manifesting in the peripheral
irculation in acute AF. Hence, contrary to permanent AF,
eripheral serological markers may not reflect intracardiac
vents (10). Furthermore, the exact AF burden in previous
tudies was heterogeneous, thereby potentially confounding
esults. The present study is the first to examine the effect of
precise AF duration on local cardiac prothrombotic events
nd to demonstrate that AF per se causes platelet activation.
ndothelial damage/dysfunction, inflammation, and
F. Although inflammation may contribute to AF patho-
enesis and hypercoagulability, the present data indicate
hat platelet activation in acute AF may not be related to
nflammation.
Experimental AF is associated with abnormal blood flow,
hear stress, and NO bioavailability leading to increased ex-
ression of prothrombotic markers (4,11). The present study
emonstrates reduced cardiac NO associated with acute hu-
an AF, implying that local endothelial dysfunction may be a
ause of platelet activation. Because platelet activation is an
arly prothrombotic event, this effect starts on a local cardiac
evel before manifesting peripherally. This hypothesis needs
urther clinical and experimental verification.
tudy limitations. The 15-min AF duration was dictated
Figure 2 Peripheral Platelet Activation
Peripheral platelet activation did not change following 15 min of either atrial
fibrillation (AF) or atrial pacing. Solid bars  baseline; open bars  15 min.y the desire not to prolong the ablation unnecessarily.
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May 6, 2008:1790–3 Acute AF and Platelet Activationuture studies need to delineate the exact time course of
emostatic system activation. This study examined platelet
ctivation change in individual patients following a defined
ntervention. Though the absolute degree of platelet activa-
ion after 15 min of AF was similar to the control group
aseline, it is the magnitude of change that is important.
he trend toward decreased cardiac platelet activation with
acing does not have a physiological explanation and is
ikely coincidental.
Coronary sinus blood reflects the total cardiac, not only
he left atrial, pool. Although local cytokines were not
ecreted after 15 min of AF, an inflammatory process is not
xcluded.
This study indirectly assessed NO production using the
reiss reaction. Demonstration of human cardiac endothe-
ial dysfunction in acute AF is difficult and requires exper-
mental verification with direct NO measurements.
onclusions
cute onset AF causes platelet activation on a local cardiac
evel. This may provide a mechanism explaining how short
pisodes of AF predispose to stroke especially in patients
ith underlying vascular disease and supports the practice of
nticoagulating patients with AF and stroke risk factors,
ven if the AF is paroxysmal.
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Figure 3 Changes in Cardiac Thrombin Generation Following AF
(A) Cardiac thrombinantithrombin complex (TAT) measured at baseline, after 15 min o
returned to baseline at the end of the procedure due to administration of intravenous-mail: jakar@lumc.edu.EFERENCES
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